Medical Health & Life Science Research News

Research report explores the biosimilars industry

Research report explores the biosimilars industry

The report “Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise & Companies) to 2021 and Biosimilars Approved & Pipeline Analysis” provides a comprehensive assessment of the fast-evolving, high-growth Global Biosimilars market.

- Agency -.

Complete repot available at www.marketreportsonline.com/504244.html.

Country Coverage of Global Biosimilars Market: United States, Canada, Argentina, Germany, France, Italy, Spain, United Kingdom, China, Japan, India, South Korea, Australia, Brazil & Mexico

Company Coverage of Global Biosimilars Market: Biocad, Celltrion Inc., Dong-A Socio Group, Pfizer Inc., Intas Pharmaceuticals Ltd., Sandoz International GmbH - A Novartis Company, Stada Arzneimittel AG, Teva Pharmaceutical Industries Ltd, Amgen Inc., Biocon, Dr. Reddy’s Laboratories, Mylan & Merck KGaA

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally.

- Agency -.

The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020.

With the continuous increasing demand for biologics, manufacturers are looking for novel strategies that will help them attain maximum returns on investment. Biosimilars are seen as the key weapon to curbing soaring healthcare costs globally.

The major factor that is driving the market for biosimilars industry is the fact that major biologics are nearing the patent cliff. Further, the lower cost of these drugs as compared to the patented biologics, the increasing encumbrance to curb healthcare costs globally, increasing nationwide government initiatives, and the strong pipeline for the biosimilar drugs is expected to fuel the biosimilars industry.

On the other hand, high manufacturing complexities and costs, stringent regulatory requirements in countries and operational challenges are restricting the growth of the biosimilars market.

Key Highlights of the Biosimilars Market Report:

Biosimilars Market - By Product Type

The erythropoietin (EPO) captures maximum share of the global biosmilars market. The Granulocyte- Colony Stimulating Factor (G-CSF) market is expected to cross US$ 6 Billion mark by 2021.

The Human Growth Hormone (HGH) biosimilars market is expected to grow with a double digit CAGR during the period 2016 - 2021. The monoclonal antibody is expected to show the highest growth rate during the period 2016 - 2021.

The insulin and interferon product segment each accounted for single digit share of the global biosimilars market respectively in 2015.

Biosimilars Market - By Applications

Among various application segments of biosimilar market, blood disorders and oncology together accounted for over 55% share of the global biosimilars market in 2015. Growth hormone deficiencies application is expected to show double digit CAGR during the period 2016 - 2021.

The chronic and autoimmune disorders captured XX% share of the biosmilars market in 2015.

Report at www.marketreportsonline.com/contacts/504244.

Biosimilars Market - By Country Wise

The market for biosimilars in the U.S. has gained momentum after the launch of Novartis’ Zarxio in September 2015.

In the European countries, Germany is at the forefront with around XX% share of the biosimilars market in 2015 followed by France with XX% share in the same year. China accounted for XX% share of the global biosimilar market in 2015.

India is seen as a key player in the biosimilar space with an exceptionally high number of approvals granted in the last decade compared to the global average. South Korea captured XX% of the global biosimilar market in 2015 being closely followed by Brazil with XX% share in the same year.

Global Biosimilars Market and Forecast - Product Types Covered: Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte- Colony Stimulating Factor (G-CSF), Monoclonal Antibody (mAb), Insulin, Interferon (IFN)

Global Biosimilars Market Applications Covered: Oncology, Blood Disorders, Growth Hormone Deficiencies, Chronic and Autoimmune Disorders

 

News From

MarketReportsOnline - Industry Research Analysis StoreMarketReportsOnline
Category: Market Research Publishers and RetailersCompany profile: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.